Introduction
!Ellagitannin-rich medicinal plant extracts and food products are currently commercialized and consumed due to their potential positive effects on diseases possessing inflammatory background. In inflammation-associated cardiovascular diseases, such products as nuts, pomegranate, blackberries, strawberries, and oak-aged red wine, were proven to exhibit beneficial effect in many human interventional studies [1][2][3][4][5][6]. A recent study conducted on people with a high cardiovascular risk has clearly shown, that regular nut intake (walnuts, almonds, and hazelnuts) significantly reduced the incidence of major cardiovascular events connected with excessive inflammatory response [7]. Although many in vitro studies conducted for extracts and single compounds deal with the explanation of the mechanism of action, the extrapolation of their results on in vivo processes raises many difficulties due to the not well-established bioavailability of ellagitannins [1]. Ellagitannins are hydrophilic, high-molecular-weight dietary polyphenols containing hexahydroxydiphenoyl subunits. They are subsequently transformed by intestinal microbiota to dibenzo [b,d]pyran-6-one derivatives, urolithins. It was established on human model that ellagitannins from strawberries, raspberries, oak-aged wine, pomegranate juice, and nuts could be transformed by intestinal microbiota to urolithins, which are the main biomarkers detected in human plasma following the intake of ellagitannin-rich food products and medicinal plants. These metabolites in contrary to ellagitannins are lipophilic compounds which have a good bioavailability and may be present in plasma in the range of 0.5 to 18.6 µM [8][9][10]. Because of their catechol-like structure after absorption they are a potential substrate for catechol-Omethyl transferase (COMT) enzyme, which increases lipophilicity and may lead to biological Abstract ! Ellagitannin-rich products exhibit beneficial influence in the case of inflammation-associated diseases. Urolithins, metabolites of ellagitannins produced by gut microbiota, in contrary to high molecular weight hydrophilic parental polyphenols, possess well established bioavailability. Because of the important role of neutrophils in progression of inflammation, the influence of urolithins on their pro-inflammatory functions was tested. Urolithin B at a concentration of 20 µM showed significant inhibition of interleukin 8 and extracellular matrix-degrading enzyme MMP-9 production. It was also significantly active in prevention of cytochalasin A/formyl-met-leuphenylalanine-triggered selectin CD62L shedding. Urolithin C was the only active compound towards inhibition of elastase release from cytochalasin A/formyl-met-leu-phenylalanine-stimulated neutrophils with 39.0 ± 15.9 % inhibition at a concentration of 5 µM. Myeloperoxidase release was inhibited by urolithins A and C (at 20 µM by 46.7 ± 16.1 and 63.8 ± 8.6 %, respectively). Urolithin A was the most potent reactive oxygen species release inhibitor both in formyl-met-leu-phenylalan...